Controlled release of a self-emulsifying formulation from a tablet dosage form: Stability assessment and optimization of some processing parameters

International Journal of Pharmaceutics

Volumn 315, Issue 1-2, 2006, Pages 110-121

  Nazzal, Sami ^a   Khan, Mansoor A ^b  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Coenzyme Q10; Controlled release; Face centered cubic design; Optimization; Self emulsified drug delivery system; Stability

Indexed keywords

DRUG CARRIER; LIPID; MAGNESIUM STEARATE; SILICATE; UBIDECARENONE;

ARTICLE; CONTROLLED DRUG RELEASE; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; EMULSION; HIGH TEMPERATURE; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL; STORAGE TEMPERATURE; TABLET FORMULATION; THERMOSTABILITY;

COENZYMES; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG INDUSTRY; DRUG STABILITY; EMULSIFYING AGENTS; LIPIDS; TABLETS; TEMPERATURE; UBIQUINONE;

EID: 33646383855     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.02.019     Document Type: Article

References (39)

1. Abdallah H.Y., Khalafallah N., and Khalil S.A. Influence of dispersion method on particle size and dissolution of griseofulvin silicon dioxide triturations. Drug Dev. Ind. Pharm. 9 (1983) 795-808
2. Alderborn G., and Nystrom C. Studies on direct compression of tablets. Part 4. Effect of particle size on the mechanical strength of tablets. Acta Pharm. Suec. 19 (1982) 381-390
3. Cannon J.B. Oral solid dosage forms of lipid-based drug delivery systems. Am. Pharmaceut. Rev. 8 (2005) 108-115
4. Carr R.L. Evaluating flow properties of solids. Chem. Eng. 18 (1965) 163-168
5. Center for Drug Evaluation and Research (CDER). Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms (1997), Food and Drug Administration, Rockville, MD
6. Charman S.A., Charman W.N., Rogge M.C., Wilson T.D., Dukto F.J., and Pouton C.W. Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharmaceut. Res. 9 (1992) 87-93
7. Craig D.Q.M., Lievens H.S.R., Pitt K.G., and Storey D.E. An investigation into the physico-chemical properties of self-emulsifying systems using low frequency dielectric spectroscopy, surface tension measurements and particle size analysis. Int. J. Pharm. 96 (1993) 147-155
8. Dabbagh M.A., Ford J.L., Rubinstein M.H., and Hogan J.E. Effects of polymer particle size, compaction pressure and hydrophilic polymers on drug release from matrices containing ethylcellulose. Int. J. Pharm. 140 (1996) 85-95
9. ® Sofcap™ for controlled release of non-aqueous liquid formulations. Drug Deliv. Technol. 2 (2002) 52-55
10. Duberg M., and Nystrom C. Studies on direct compression of tablets XVII. Porosity-pressure curves for the characterization of volume reduction mechanisms in powder compression. Powder Technol. 46 (1986) 67-75
11. Gao Z.G., Choi H.G., Shin H.J., Park K.M., Lim S.J., Hwang K.J., and Kim C.K. Physicochemical characterization and evaluation of a microemulsion system for oral delivery of cyclosporine A. Int. J. Pharm. 161 (1998) 75-86
12. Hariharan M., Wheatley T.A., and Price J.C. Controlled-release tablet matrices from carrageenans: compression and dissolution studies. Pharm. Dev. Technol. 2 (1997) 383-393
13. Jannin V., and Chambin O. Self emulsifying drug delivery systems. STP Pharma Pratiques 15 (2005) 247-254
14. Johansson M.E., and Nicklasson M. Investigation of the film formation of magnesium stearate by applying a flow through dissolution technique. J. Pharm. Pharmacol. 38 (1986) 51-54
15. Khan K.A., Musikabhumma P., and Rubinstein M.H. Effect of mixing time of magnesium stearate on the tableting properties of dried microcrystalline cellulose. Pharm. Acta Helv. 58 (1983) 109-111
16. Kim C., Shin H., Yang S., Kim J., and Oh Y. Once-a-day oral dosing regimen of cyclosporine A: combined therapy of cyclosporine A premicroemulsion concentrates and enteric coated solid-state premicroemulsion concentrates. Pharmaceut. Res. 18 (2001) 454-459
17. Lerk C.F., and Bolhuis G.K. Interaction of lubricants and colloidal silica during mixing with excipients. 2. Its effect on wettability and dissolution velocity. Pharm. Acta Helv. 52 (1977) 39-44
18. Liao C., and Jarowski C.I. Dissolution rates of corticoid solutions dispersed on silicas. J. Pharm. Sci. 73 (1984) 401-403
19. Moore J.W., and Flanner H.H. Mathematical comparison of dissolution profiles. Pharm. Technol. 20 (1996) 64-74
20. Morasso M.I., Salas J., and Arancibia A. Effect of mixing on the biopharmaceutical properties of sulfadiazine tablets. Farmaco Ed. Prat. 43 (1988) 177-188
21. ®, Statistical Experiment Design, Data Analysis and Nonlinear Optimization (1994), Wiley, New York
22. Nazzal S., and Khan M.A. Response surface methodology for the optimization of ubiquinone self-emulsified drug delivery system. AAPS PharmSciTech. 3 (2002) (article 3)
23. ® solid dispersion. Drug Dev. Ind. Pharm. 28 (2002) 49-57
24. Nazzal S., Nutan M., Palamakula A., Shah R., Zaghloul A.A., and Khan M.A. Optimization of a self-nanoemulsified tablet dosage form of ubiquinone using response surface methodology: effect of formulation ingredients. Int. J. Pharm. 240 (2002) 103-114
25. Nazzal S., Smalyukh I.I., Lavrentovich O.D., and Khan M.A. Preparation and in-vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation. Int. J. Pharm. 235 (2002) 247-265
26. Nazzal S., Zaghloul A.A., and Khan M.A. Effect of extra-granular microcrystalline cellulose on compaction, surface roughness and in-vitro dissolution of a self-nanoemulsified solid dosage form of ubiquinone. Pharmaceut. Technol. 26 (2002) 86-98
27. 10) aqueous samples using reversed phase liquid chromatography. Die Pharm. 56 (2001) 394-396
28. Newton R.M., Petterson J., Podczeck F., Clarke A., and Booth S. The influence of formulation variables on the properties of pellets containing a self-emulsifying mixture. J. Pharm. Sci. 90 (2001) 987-995
29. Perng C.H., Kearney A.S., Patel K., Palepu N.R., and Zuber G. Investigation of formulation approaches to improve the dissolution of SB-210661, a poorly water soluble 5-lipoxygenase inhibitor. Int. J. Pharm. 176 (1998) 31-38
30. Pouton C.W. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. Eur. J. Pharm. Sci. (2000) S93-S98
31. Rehula A., Rehulova M., and Muzik M. Effect of changes in compression pressure on dissolution of drugs from tablets. Folia Pharm. 8 (1985) 35-42
32. Sjokvist E., and Nystrom C. Physicochemical aspects of drug release. Part 11. Tableting properties of solid dispersions, using xylitol as carrier material. Int. J. Pharm. 67 (1991) 139-153
33. Sjokvist E., Nystrom C., and Alden M. Physicochemical aspects of drug release. Part 9. Investigation of some factors that impair dissolution of drugs from solid particulate dispersion systems. Int. J. Pharm. 54 (1989) 161-170
34. Spireas S.S., Jarowski C.I., and Rohera B.D. Powdered solution technology: principles and mechanism. Pharm. Res. 9 (1992) 1351-1358
35. Spireas S., and Sadu S. Enhancement of prednisolone dissolution properties using liquisolid compacts. Int. J. Pharm. 166 (1998) 177-188
36. Sun C., and Grant D.J.W. Effect of initial particle size on the tableting properties of l-lysine monohydrochloride dihydrate powder. Int. J. Pharm. 215 (2001) 221-228
37. Takashima Y., Yuasa H., Kanaya Y., Nomura I., and Shinozawa K. Reduction of tablet coloration at tableting for oily medicine (tocopheryl nicotinate). Int. J. Pharm. 187 (1999) 125-135
38. Wang L.H., and Chowhan Z.T. Drug-excipient interactions resulting from powder mixing. Part 5. Role of sodium lauryl sulfate. Int. J. Pharm. 60 (1990) 61-78
39. Yang K.Y., Glemza R., and Jarowski C.I. Effect of amorphous silicon dioxide on drug dissolution. J. Pharm. Sci. 68 (1979) 560-565